Why Akso Health Group’s (AHG) Stock Is Down 7.23%
As of Friday, July 31, Akso Health Group’s AHG share price has dipped by 7.23%, which has investors questioning if this is right time to buy.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Michael Rose
Jenna Brashear
Cynthia McLaughlin
Jenna Brashear
| Share Statistics | AHG | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,345.0 | $1,742.7 | 49% |
|
| Shares Out (Mil) | 856.3 | 76.7 | 93% |
|
| Institutional Ownership | na | 89.7% | na |
|
| Float (Mil) | 854.0 | 49.4 | 90% |
|
| Beta | -1.00 | 0.82 | 1% |
|
| Avg Daily Volume (000s) | 9 | 521 | 16% |
|
| Price Change (52-week) |
(21.5%) | 78.7% | 30% |
|
| Growth | AHG | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.0% | na |
|
| Net Income (5yr) | 11.7% | (0.7%) | 58% |
|
| EPS (5yr) | 57.4% | 3.1% | 95 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | (23.9%) | (18.0%) | 27% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AHG | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $14 | $1,456 | 11% |
|
| Net Income (TTM) (Mil) | ($19) | $12 | 24% |
|
| EPS (TTM) | ($0.026) | $0.300 | 38% |
|
| Operating Cash Flow (TTM) (Mil) | ($13) | $138 | 18% |
|
| Net Cash Flow (TTM) (Mil) | na | $8 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $316 | 0% |
|
| Enterprise Value (Q1) (Mil) | $1,253 | $2,170 | 44% |
|
| Valuation | AHG | Industry Median |
Percentile (All Stocks) |
|
| P/B | 7.48 | 2.85 | 86% |
|
| P/E | na | 26.7 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | AHG | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (0.1%) | 27.8% | 4% |
|
| Net Margin | (135.0%) | 1.1% | 6% |
|
| ROA | (9.2%) | 1.8% | 26% |
|
| ROE | (9.8%) | 7.1% | 28% |
|
| Liabilities to Assets | 4.6% | 59.9% | 2% |
|
| F-Score | 4 | 5 | 34% |
|
Akso Health Group did not pass any screens on 7/31/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors